Terms: = Breast cancer AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR
37 results:
1. Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative breast cancer.
Gardi N; Chaubal R; Parab P; Pachakar S; Kulkarni S; Shet T; Joshi S; Kembhavi Y; Chandrani P; Quist J; Kowtal P; Grigoriadis A; Sarin R; Govindarajan R; Gupta S
Cancer Res Commun; 2024 Feb; 4(2):404-417. PubMed ID: 38315150
[TBL] [Abstract] [Full Text] [Related]
2. Detection of internal mammary chain infiltration in breast cancer patients by [
Garcia JR; Kauak M; Compte A; Bassa P; Llinares E; Valls E; Riera E
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(2):73-78. PubMed ID: 37865228
[TBL] [Abstract] [Full Text] [Related]
3. Application of carbon nanoparticles combined with refined extracapsular anatomy in endoscopic thyroidectomy.
Wang Z; Bo H; Xu Y; Bi Z; Yin Z; Yu C; Luo E; Shi X; Chen B; Wang Y; Sha R
Front Endocrinol (Lausanne); 2023; 14():1131947. PubMed ID: 37334307
[TBL] [Abstract] [Full Text] [Related]
4. Automated Triage of Screening breast MRI Examinations in High-Risk Women Using an Ensemble Deep Learning Model.
Bhowmik A; Monga N; Belen K; Varela K; Sevilimedu V; Thakur SB; Martinez DF; Sutton EJ; Pinker K; Eskreis-Winkler S
Invest Radiol; 2023 Oct; 58(10):710-719. PubMed ID: 37058323
[TBL] [Abstract] [Full Text] [Related]
5. Improving the patient-reported outcome sections of clinical trial protocols: a mixed methods evaluation of educational workshops.
King MT; Tait MA; Campbell R; Müller F; Rutherford C; Beckmore C; Chima S; Langbecker D; Shaw J; Mercieca-Bebber R
Qual Life Res; 2022 Oct; 31(10):2901-2916. PubMed ID: 35553325
[TBL] [Abstract] [Full Text] [Related]
6. breast cancer trends in women younger than 40 years in Brazil.
Bonadio RC; Moreira OA; Testa L
Cancer Epidemiol; 2022 Jun; 78():102139. PubMed ID: 35290906
[TBL] [Abstract] [Full Text] [Related]
7. [Ramadan fasting during treatment with external beam radiotherapy].
Lachgar A; Ridai S; Mouafik S; Kaiss H; Sahli N; Jouhadi H; Benider A
Bull Cancer; 2022 Mar; 109(3):331-337. PubMed ID: 34776116
[TBL] [Abstract] [Full Text] [Related]
8. Systematic Review and Meta-Analysis of Complications Following Mastectomy and Prosthetic Reconstruction in Patients With and Without Prior breast Augmentation.
Chicco M; Ahmadi AR; Cheng HT
Aesthet Surg J; 2021 Jun; 41(7):NP763-NP770. PubMed ID: 33480970
[TBL] [Abstract] [Full Text] [Related]
9. EMT Transcription Factor ZEB1 Represses the Mutagenic POLθ-Mediated End-Joining Pathway in breast cancers.
Prodhomme MK; Pommier RM; Franchet C; Fauvet F; Bergoglio V; Brousset P; Morel AP; Brunac AC; Devouassoux-Shisheboran M; Petrilli V; Moyret-Lalle C; Hoffmann JS; Puisieux A; Tissier A
Cancer Res; 2021 Mar; 81(6):1595-1606. PubMed ID: 33239429
[TBL] [Abstract] [Full Text] [Related]
10. cancer awareness in the general population varies with sex, age and media coverage: A population-based survey with focus on gynecologic cancers.
Fonnes T; Telle IO; Forsse D; Falck R; Trovik J; Haldorsen IS; Krakstad C
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():25-31. PubMed ID: 33161211
[TBL] [Abstract] [Full Text] [Related]
11. HiFreSP: A novel high-frequency sub-pathway mining approach to identify robust prognostic gene signatures.
Li M; Zhao J; Li X; Chen Y; Feng C; Qian F; Liu Y; Zhang J; He J; Ai B; Ning Z; Liu W; Bai X; Han X; Wu Z; Xu X; Tang Z; Pan Q; Xu L; Li C; Wang Q; Li E
Brief Bioinform; 2020 Jul; 21(4):1411-1424. PubMed ID: 31350847
[TBL] [Abstract] [Full Text] [Related]
12. Body Composition, Serum Biomarkers of Inflammation and Quality of Life in Clinically Stable Women with Estrogen Receptor Positive Metastatic breast cancer.
Sheean P; Gomez-Perez S; Joyce C; Vasilopoulos V; Bartolotta MB; Robinson P; Lo S; Lomasney L
Nutr Cancer; 2019; 71(6):981-991. PubMed ID: 31037968
[TBL] [Abstract] [Full Text] [Related]
13. The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis.
Lee KWC; Lord S; Finn RS; Lim E; Martin A; Loi S; Lynch J; Friedlander M; Lee CK
Breast Cancer Res Treat; 2019 Feb; 174(1):271-278. PubMed ID: 30465154
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative breast cancer.
Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
[TBL] [Abstract] [Full Text] [Related]
15. Mechanisms of Acquired Resistance to Trastuzumab Emtansine in breast cancer Cells.
Li G; Guo J; Shen BQ; Yadav DB; Sliwkowski MX; Crocker LM; Lacap JA; Phillips GDL
Mol Cancer Ther; 2018 Jul; 17(7):1441-1453. PubMed ID: 29695635
[TBL] [Abstract] [Full Text] [Related]
16. Platinum-containing regimens for metastatic breast cancer.
Egger SJ; Willson ML; Morgan J; Walker HS; Carrick S; Ghersi D; Wilcken N
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003374. PubMed ID: 28643430
[TBL] [Abstract] [Full Text] [Related]
17. The prognostic significance of Cdc6 and Cdt1 in breast cancer.
Mahadevappa R; Neves H; Yuen SM; Bai Y; McCrudden CM; Yuen HF; Wen Q; Zhang SD; Kwok HF
Sci Rep; 2017 Apr; 7(1):985. PubMed ID: 28428557
[TBL] [Abstract] [Full Text] [Related]
18. Granulocyte-Colony Stimulating Factor Receptor, Tissue Factor, and VEGF-R Bound VEGF in Human breast cancer In Loco.
Wojtukiewicz MZ; Sierko E; Skalij P; Kamińska M; Zimnoch L; Brekken RA; Thorpe PE
Adv Clin Exp Med; 2016; 25(3):505-11. PubMed ID: 27629739
[TBL] [Abstract] [Full Text] [Related]
19. Validation of associations between ESR1 variants and breast cancer risk in Chinese cohorts.
Li X; Yao GY; Li FX; Qiu YR; Yang XX
Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525837
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of pigmentary side effects of taxanes and anthracyclines: an onychoscopic evaluation.
Yorulmaz A; Dogan M; Artuz F; Zengin N
Cutan Ocul Toxicol; 2017 Jun; 36(2):135-139. PubMed ID: 27086693
[TBL] [Abstract] [Full Text] [Related]
[Next]
